| EURO-CELTIQUE S.A. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120101118 | TAMPER RESISTANT DOSAGE FORMS - Tamper resistant controlled release formulations. | 04-26-2012 |
| 20120093929 | Opioid Composition for Treating Skin Lesions - The present invention relates to a composition, comprising (i) a matrix made of polymeric nanofibers, and (ii) an opioid agonist within the matrix. | 04-19-2012 |
| 20120017900 | Counter - The present invention provices a counter comprising: a first member disposed in at least a partial helical turn about a longitudinal axis of an entity whose movements and/or contents are to be counted, said first member having an indicium or indicia indicative of a count; a second member extending generally in the direction of said longitudinal axis, said second member being operatively disposed in overlapping relationship under and over one or more portions of said at least partial helical turn of said first member; and means to effect relative movement between said first and second members, said movement comprising a relative incremental rotation about said longitudinal axis. | 01-26-2012 |
| 20120010231 | Dihydroetorphines and Their Preparation - The present invention provides a process for the preparation of a compound of formula (VI), or a salt or derivative thereof, wherein R | 01-12-2012 |
| 20100087470 | Buprenorphine-Wafer for Drug Substitution Therapy - The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects. | 04-08-2010 |
| 20100047337 | PHARMACEUTICAL SPHEROIDS - According to the invention glyceryl monostearate and a polymeric binder are employed as a spheronising aid in the manufacture of pharmaceutical spheroids containing no or substantially no microcrystalline cellulose. The spheroids can contain one or more therapeutically active agent which undergoes no or substantially no degradation when stored under accelerated temperature and humidity conditions. A coating may be applied to the spheroids; when present, the coating is preferably a controlled release coating. | 02-25-2010 |
| 20090324694 | GASTRORETENTIVE DRUG DELIVERY SYSTEM COMPRISING AN EXTRUDED HYDRATABLE POLYMER - According to the present invention there is provided a pharmaceutical product for retention in the stomach. The product is produced by extrusion. The use of extrusion enables the product to take many useful forms. The product may comprise a sheet of hydratable polymer, the hydrated sheet being of a size which will not pass out of the stomach, for example a shaped sheet or a roll. The product may also comprise a scaled hollow tubular extrudate, for example a tube scaled at both ends. The product may comprise a filled capsule. | 12-31-2009 |
| 20090169626 | TAMPER RESISTANT DOSAGE FORMS - Tamper resistant controlled release formulations. | 07-02-2009 |
| 20090118319 | Fused and Spirocycle Compounds and the Use Thereof - The invention relates to fused and spirocycle compounds of Formula (I), or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R | 05-07-2009 |
| 20090118248 | 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof - The invention relates to a novel multi step process of making compounds of Formula I: | 05-07-2009 |
| 20090105249 | 4-phenylsulfonamidopiperidines as calcium channel blockers -
The invention relates to piperidinyl compounds of Formula (I): or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R | 04-23-2009 |
| 20090022780 | HYDROGEL - The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds. | 01-22-2009 |
| 20080233178 | Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres - The present invention provides abuse-resistant transdermal delivery devices containing an opioid agonist intended for analgesic purposes in pain patients. | 09-25-2008 |
| 20080214827 | Synthesis of Cyanoimino-Benzoimidazoles - Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof. | 09-04-2008 |
| 20080200493 | Use of Oxycodone for Treating Visceral Pain - It is possible to effectively treat moderate to severe visceral pain by administering analgesic medications comprising the opioid oxycodone or pharmaceutically acceptable salts thereof. Visceral pain and especially acute (i.e. non-chronic) visceral pain can be effectively treated by administering oxycodone at a dosage which is lower than the corresponding dosage of other opioids like morphine. | 08-21-2008 |
